PLEASE CALL US FOR AN APPOINTMENT
We offer stem cell therapies for the following heart and lung conditions and diseases:
Stem Cell Heart Repair
Stem cells are responsible for responding to, surveying, and healing injury to the body. When the heart has been damaged the signal that would normally be sent for stem cells to respond and form new, healthy heart cells ceases. This results in damaged heart tissue, which makes it challenging for the heart to contract and move blood, eventually resulting in heart failure.
Post Myocardial Infarction (Heart Attack)
After a myocardial infarction, the heart suffers from permanent loss of heart muscle cells and formation of scar tissue, which severely diminishes cardiac function. Stem cell therapy offers a potential source of myocardial regeneration.
Congestive Heart Failure (CHF) & Cardiomyopathy
Congestive Heart Failure (CHF) results when the heart is not pumping optimally. Because the body depends on the heart to deliver oxygen and nutrient-rich blood, CHF results in fatigue and shortness of breath. A possible cause of CHF is cardiac ischemia, when the heart is starved of oxygen. Cardiac ischemia results in the destruction of millions of myocytes (heart cells), which decreases contractility and leads to heart failure. Cardiomyopathy, deterioration or weakening of the heart muscles, is often a consequence of CHF, since, in its struggle to keep up with the body’s demands, the heart compensates by enlarging, developing more muscle mass, and/or pumping faster. The regenerative capability of stem cells offer hope in regenerating damaged heart muscle and mitigating heart failure through deployment of mesenchymal stem cells intravenously, injection directly into the heart muscle, and/or placement into coronary arteries.
Chronic Obstructive Pulmonary Disease (COPD) involves inflammation in the lungs as well as systemically. Stem cell therapy may provide a reduction in inflammation and improve lung function and quality of life. (See Asthma)
Asthma involves the inflammation and narrowing of airways, resulting in wheezing, chest tightness, coughing, and shortness of breath. Stem cells are powerful immune modulators that can reduce inflammation. Current investigations are being made into the anti-inflammatory and immune-modulatory properties of adult stem cells in treating reactive airways.
Cardiac Patient Testimonial:
60-Something Class IV heart failure patient, 2 months following stem cell procedure:
“I feel terrific! I’m able to walk better and my breathing has improved 90%. I can now do laundry, clean, walk from the sidewalk to my house without a wheelchair and shower independently. This is a big improvement. I recently had a consult with my primary cardiologist, who was very pleased with my heart and lung function.”
Read more patient testimonials
Cardiac Patient Testimonial:
“She just called to report her BP this AM, which was 118/75 with pulse 80 bpm. She also wanted to pass along some “good news” that after going out grocery shopping yesterday with her daughter, she was able to unload the groceries and put them away without getting out of breath and she has “not felt this way in a long time”. That feeling lasted 10 minutes and then her SOB returned; however, after she rested for a short while, she felt well again and not out of breath, which is progress for her.”
Pulmonary, Patient Testimonial:
“…Still going strong and completely asymptomatic. [I’ve] recorded my highest breathing scores last week having been completely medicine free – something I could never do, even with 2 inhalers, 2 asthma pills and 4 daily breathing treatments. It was my fastest doctor’s appointment ever…”
Cardiac Patient Testimonial:
“Angelika just called to report her BP this AM, which was 118/75 with pulse 80 bpm. She also wanted to pass along some “good news” that after going out grocery shopping yesterday with her daughter, she was able to unload the groceries and put them away without getting out of breath and she has “not felt this way in a long time”. That feeling lasted 10 minutes and then her SOB returned; however, after she rested for a short while, she felt well again and not out of breath, which is progress for her.”
Evidence for Cardiomyocyte Renewal in Humans
The capacity to generate cardiomyocytes in the adult human heart suggests that it may be rational to work towards the development of therapeutic strategies aiming to stimulate this process in cardiac pathologies.
Read more related articles
Blocking one inflammatory pathway improves rheumatoid arthritis but increases risk for heart disease: Why ozone, Asea and other modulatory therapies make so much more sense
Inflammation – the body’s response to damaging stimuli – may have a protective effect against cardiovascular disease, according to a new study. The finding is one of the outcomes of research using a powerful new genetic tool that mimics the behaviour of certain anti-inflammatory drugs. read more
Mesenchymal Stem Cells and Their Potential as Cardiac Therapeutics
The Editor’s Roundtable: Advances in Stem Cell Therapy for Treatment of Cardiovascular Disease
Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine
Mesenchymal Stem Cells: Future Source for Reparative Medicine
Current treatments for ischemic cardiomyopathy are aimed toward minimizing the deleterious consequences of damaged myocardium. The possibility of treating heart failure by generating new myocardium and vascular structures has provided major impetus for recent stem cell research.
Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction
Therapeutic advances in prevention and treatment of myocardial infarction (MI) have decreased patient mortality and increased concern about efficient repair and scar formation…